Erik Herman

2.0k total citations
66 papers, 1.6k citations indexed

About

Erik Herman is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Erik Herman has authored 66 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 19 papers in Molecular Biology and 10 papers in Psychiatry and Mental health. Recurrent topics in Erik Herman's work include Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cancer Treatment and Pharmacology (6 papers). Erik Herman is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (19 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Cancer Treatment and Pharmacology (6 papers). Erik Herman collaborates with scholars based in United States, Czechia and Canada. Erik Herman's co-authors include V J Ferrans, V.S. Waravdekar, Brian B. Hasinoff, K. Hellmann, P. Schein, John F. Van Vleet, A Rahman, Jun Zhang, Charles E. Myers and Douglas P. Chadwick and has published in prestigious journals such as Circulation, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Erik Herman

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Herman United States 22 797 508 311 246 205 66 1.6k
Paola Altieri Italy 28 700 0.9× 365 0.7× 594 1.9× 24 0.1× 171 0.8× 77 2.3k
O Bellini Italy 18 610 0.8× 259 0.5× 615 2.0× 17 0.1× 90 0.4× 46 1.4k
Mason Jw United States 11 871 1.1× 375 0.7× 147 0.5× 11 0.0× 95 0.5× 20 1.2k
Ronald G. Schwartz United States 22 1.3k 1.7× 382 0.8× 187 0.6× 10 0.0× 127 0.6× 47 2.1k
Laura Gilliam United States 16 300 0.4× 283 0.6× 708 2.3× 41 0.2× 46 0.2× 51 1.6k
Martina Weber Germany 19 298 0.4× 133 0.3× 388 1.2× 40 0.2× 57 0.3× 32 1.5k
М. И. Волкова Russia 8 422 0.5× 261 0.5× 192 0.6× 21 0.1× 56 0.3× 71 829
Inger Wallin Sweden 27 36 0.0× 562 1.1× 364 1.2× 37 0.2× 156 0.8× 48 1.7k
Jian Ma China 26 339 0.4× 274 0.5× 1.1k 3.5× 17 0.1× 291 1.4× 90 2.1k
Paul Chrisp United Kingdom 17 79 0.1× 180 0.4× 266 0.9× 211 0.9× 48 0.2× 24 1.3k

Countries citing papers authored by Erik Herman

Since Specialization
Citations

This map shows the geographic impact of Erik Herman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Herman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Herman more than expected).

Fields of papers citing papers by Erik Herman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Herman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Herman. The network helps show where Erik Herman may publish in the future.

Co-authorship network of co-authors of Erik Herman

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Herman. A scholar is included among the top collaborators of Erik Herman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Herman. Erik Herman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fagiolini, Andrea, Umberto Albert, Laura Ferrando, et al.. (2020). A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder. International Clinical Psychopharmacology. 35(3). 137–146. 27 indexed citations
2.
Nežádal, Tomáš, et al.. (2011). Psychogenic non-epileptic seizures: our video-EEG experience. Neurological Research. 33(7). 694–700. 13 indexed citations
3.
Praško, Ján, et al.. (2007). Disociativní poruchy a jejich léčba. 4(11). 471–476.
4.
5.
Herman, Erik, et al.. (2006). Psychiatrické aspekty epilepsie. Neurologie pro praxi. 6(2). 89–94.
6.
Herman, Erik. (2004). Lamotrigine: a depression mood stabiliser. European Neuropsychopharmacology. 14. S89–S93. 14 indexed citations
7.
Herman, Erik, et al.. (2000). Treatment of Interictal Depression with Citalopram in Patients with Epilepsy. Epilepsy & Behavior. 1(6). 444–447. 69 indexed citations
8.
Hasinoff, Brian B., K. Hellmann, Erik Herman, & V J Ferrans. (1998). Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines. Current Medicinal Chemistry. 5(1). 1–28. 131 indexed citations
9.
Herman, Erik & V J Ferrans. (1998). Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.. PubMed. 25(4 Suppl 10). 15–21. 89 indexed citations
10.
11.
Herman, Erik. (1995). Morphologic and morphometric evaluation of the effect of ICRF-187 on bleomycin-induced pulmonary toxicity. Toxicology. 98(1-3). 163–175. 28 indexed citations
12.
Yamamoto, Akiyuki, et al.. (1995). Immunofluorescence techniques for the identification of immune effector cells in rat heart: applications to the study of the myocarditis induced by interleukin-2. Journal of Molecular and Cellular Cardiology. 27(1). 307–319. 5 indexed citations
13.
Herman, Erik, Jun Zhang, & Victor J. Ferrans. (1994). Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats. Cancer Chemotherapy and Pharmacology. 35(2). 93–100. 48 indexed citations
14.
Fukuda, Yoko, Erik Herman, & V J Ferrans. (1992). Effect of ICRF-187 on the pulmonary damage induced by hyperoxia in the rat. Toxicology. 74(2-3). 185–202. 11 indexed citations
15.
Herman, Erik, V J Ferrans, Charles E. Myers, & John F. Van Vleet. (1985). Comparison of the effectiveness of (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles.. PubMed. 45(1). 276–81. 101 indexed citations
16.
Herman, Erik, et al.. (1973). A Comparison of the Cardiovascular Actions of Thalicarpine and its Moieties. Pharmacology. 10(3). 178–187. 3 indexed citations
17.
Herman, Erik, et al.. (1971). The possible relationship between metabolism and cardiac toxicity of duanomycin and related compounds.. PubMed. 178(1). 216–22. 30 indexed citations
18.
Herman, Erik & James A. Vick. (1970). The Acute Pharmacological Actions of Daunomycin in the Dog and Monkey. Pharmacology. 3(5). 291–304. 8 indexed citations
19.
Herman, Erik, et al.. (1969). Comparative Cardiac Toxicity of Daunomycin in Three Rodent Species. Experimental Biology and Medicine. 130(4). 1098–1102. 11 indexed citations
20.
Walton, R. P., et al.. (1966). Structural Specificity of Dextran in Producing Anaphylactoid Reactions in Rats.. Experimental Biology and Medicine. 121(1). 272–274. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Altieri Breakdown of academic impact, for papers by O Bellini Breakdown of academic impact, for papers by Mason Jw Breakdown of academic impact, for papers by Ronald G. Schwartz Breakdown of academic impact, for papers by Laura Gilliam Breakdown of academic impact, for papers by Martina Weber Breakdown of academic impact, for papers by М. И. Волкова Breakdown of academic impact, for papers by Inger Wallin Breakdown of academic impact, for papers by Jian Ma Breakdown of academic impact, for papers by Paul Chrisp
Rankless by CCL
2026